Edition:
United States

Insight: Cancer drugs proving worth earlier in testing

Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
1 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
2 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
3 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
4 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
5 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
6 / 7
Photographer
� Bret Hartman / Reuters

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman

Dr. Michael Weitz, MD, poses in the emergency room at St. John's Health Center in Santa Monica, California, February 13, 2013. Drug makers are finding out much earlier in the testing process whether cancer drugs work and Dr. Weitz, whose lung cancer was quickly eradicated in a Phase 1 trial, is an example of this trend. Picture taken February 13, 2013. REUTERS/Bret Hartman
Close
7 / 7

All Collections

Republicans face town hall protests

Wednesday, February 22, 2017

All Collections

Fleeing to Canada from the U.S.

Wednesday, February 22, 2017

All Collections

Best of the BRIT Awards

Wednesday, February 22, 2017

All Collections

Flooding in San Jose

Wednesday, February 22, 2017

All Collections

First 100 days of Trump

Wednesday, February 22, 2017

All Collections

Distant planets

Wednesday, February 22, 2017

All Collections

Iraqi forces push into Mosul

Wednesday, February 22, 2017

All Collections

Escape from Islamic State

Wednesday, February 22, 2017